Let AI watch the worldβs key changes for you unkAI
unkAI continuously tracks the public intelligence and global changes you care about, and only alerts you when noteworthy new developments emerge. Subscribe for free by email β no repeated interruptions, no missed key changes.
Health
72 items Β· Recommended
Approval timeline for the new domestic anti-hair loss drug KX-826
Follow up on the progress of KX-826's NDA submission to the National Medical Products Administration, acceptance status, review process, arrangements for supplementary information submission, and the final approval and listing timeline.
Changes in the NDA approval efficiency of domestically developed innovative drugs
Observe the approval cycle from application acceptance to approval of domestic first-in-class drugs such as KX-826, and compare the impact of the priority review channel on the launch speed of innovative drugs.
U.S. FDA approval nodes for new generation GLP-1 drugs
Track PDUFA approval dates, approval results and new indication expansions of new generation GLP-1 drugs from pharmaceutical companies such as Eli Lilly and Novo Nordisk.
Growth dynamics of China's cell therapy market size
Follow the development of China's domestic cell therapy industry, and pay attention to changes in the number of approved products, market size growth, corporate R&D investment and commercialization progress.
Progress of Ebola epidemic prevention and control in the DRC
Track daily new confirmed cases and death data, monitor progress of clinical trials of candidate drugs, and focus on whether the epidemic has peaked and the implementation of international aid.
Clinical progress of Neuralink's brain-computer interface
Follow up on changes in clinical trial results, medical indication expansion and commercial approval progress of implantable brain-computer interfaces.
Dynamics of the implementation of AI-assisted medical diagnosis pilot projects
Observe the pilot progress, diagnostic accuracy optimization, compliance approval progress and clinical application expansion of AI-assisted medical diagnosis in different medical institutions.
Subscription results of SinoNova Sci-Tech Innovation Board IPO
Follow up on the subscription data, winning rate, approval result and post-listing stock price trend change of SinoNova's STAR Market IPO.
FDA approval timeline for GSK's acquisition of Nuvalent's lung cancer inhibitors
Follow up on the FDA PDUFA approval progress and result changes of the two next-generation ROS1/ALK lung cancer inhibitors obtained by GSK through the acquisition of Nuvalent.
Compliance development trends of China's medical aesthetics industry
Observe the implementation of regulatory policies for China's medical aesthetics industry, follow up on changes in the opening up of imported device access, market share of compliant institutions, and commercialization progress of domestic regenerative materials.
The growth dynamics of China's innovative drug out-licensing
Follow up on changes in transaction volume, market expansion and progress dynamics of Chinese innovative drugs' out-licensing and innovative going-global.
Approval timeline for nystatin suspension in China
Follow the review cycle changes of this drug for production declaration, keep up with the final approval result and expected approval time adjustment.